Psoriasis
📧 Sign up to get email alerts when something new happens for Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Safety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled trial is evaluating the safety and efficacy of Lactobacillus plantarum for psoriasis;…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis
The clinical trial NCT07298265 evaluating physician- versus questionnaire-based screening for psoriatic arthritis in psoriasis patients is c…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), With EU-approved Skyrizi®, and US-licensed Skyrizi® in Healthy Adult Participants [Phase 1]
Phase 1 clinical trial comparing pharmacokinetics, safety, tolerability, and immunogenicity of CKD-704, a risankizumab biosimilar, with EU- …
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis [Phase 1]
Phase 1 clinical trial update describing safety and pharmacokinetics evaluation of LPX-TI641 in adults with atopic dermatitis and psoriasis.…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Is There a Benefit From Addition of Treadmill Walking to Diet Restriction in Psoriasis Women With PCOS? [NA]
A clinical trial is recruiting to assess whether adding treadmill walking to diet restriction improves outcomes in women with psoriasis and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant) [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating post-inflammatory pigment alteration after psoriasis treatment (PIPA) involving Dermavant; enrol…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Use of Transcutaneous Electrical Nerve Stimulation for Reducing Biologic Injection Site Pain(TENS Study) [NA]
This clinical trial update reports on using transcutaneous electrical nerve stimulation (TENS) to reduce injection-site pain from biologic t…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: A Trial of Academic Detailing to Promote Prescribing of Biosimilars [NA]
This clinical trial update describes an academic detailing intervention intended to promote prescribing of biosimilars among clinicians trea…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage [Phase 1]
This is a Phase 1 pharmacokinetic study evaluating Hemay005 tablets in subjects with psoriasis to assess how liver damage affects drug expos…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis [EARLY_Phase 1]
An early Phase 1 trial comparing oral methotrexate with tofacitinib for chronic plaque psoriasis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Pilot Study to Assess How Safe and Effective Oral Roflumilast is for Treating Moderate to Severe Psoriasis in Adults [Phase 2]
A Phase 2 pilot trial is evaluating the safety and effectiveness of oral roflumilast for adults with moderate-to-severe psoriasis; the study…
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy
This clinical trial update reports real-world use of deucravacitinib for moderate-to-severe psoriasis in Italy, with ongoing recruitment.
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Pharmacokinetic, Safety and Immunogenicity Study of New Process CMAB015 and Cosentyx in Healthy Volunteers [Phase 1]
A Phase 1 pharmacokinetic, safety and immunogenicity study comparing the new process CMAB015 with Cosentyx in healthy volunteers.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Tilrdakizumab Almirall
A clinical trial evaluating tilrdakizumab for psoriasis is currently active but not recruiting at University Hospital Schleswig-Holstein.
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
A clinical trial is evaluating an educational tool to help melanoma patients with pre-existing autoimmune diseases who are candidates for im…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study [Phase 4]
Phase 4 MEMPSOLAR trial evaluating residual disease memory in psoriasis skin during EnstiLAR therapy and narrow-band UVB treatment; the stud…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Safety and Efficacy of RAP-103 to Improve Severity and Quality of Life on Moderate to Severe Psoriasis in Subjects [Phase 2]
A Phase 2 clinical trial update describes safety and efficacy goals for RAP-103 in adults with moderate-to-severe psoriasis; the study is no…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis
Phase 4 multicenter, open-label trial evaluating the efficacy and safety of apremilast in moderate-to-severe psoriasis. Sponsored by Daewoon…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction [NA]
A clinical trial is evaluating a novel skin barrier product against petrolatum for skin barrier dysfunction and is currently recruiting at M…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis
A clinical study evaluating how prevalent cardiovascular comorbidity is among patients with psoriasis and identifying associated risk factor…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: A Phase 2 Study of HB0017 in Psoriasis Patients [Phase 2]
Phase 2 clinical trial update for HB0017 in psoriasis, currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Microbiome and Clinical Response to Probiotics and Methotrexate in Early Psoriasis: a Pilot Study [EARLY_Phase 1]
An early Phase 1 pilot trial exploring whether probiotics combined with methotrexate can influence the microbiome and clinical response in p…
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Pathogenesis of Periodontal Disease in Individuals With Psoriasis
This clinical trial protocol studies how periodontal disease develops in people with psoriasis. Recruitment has not yet begun.
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers [Phase 4]
This multi-center Phase 4 trial is evaluating personalized precision medicine for psoriasis and psoriatic arthritis, with an investigation o…
-
CLINICAL_TRIALS research · 2025-09-02Clinical Trial Update: A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis [Phase 2]
This document describes a Phase II clinical trial evaluating HSK44459 for moderate to severe plaque psoriasis, with the trial currently not …